# Temporary Vascular Occlusion Clamp (TVOC)

Canonical: https://abierto.us/opportunities/fa238424cb015

- Solicitation number: FA238424CB015
- Notice type: Award notice
- Status: Awarded to Amsel Medical Corporation for $7,453,975.00
- Department: Department of the Air Force
- Agency: Department of the Air Force
- Contracting office: FA2384 USAF AFMC AFRL PZL AFRL Rakh (FA2384)
- NAICS: 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance: Cambridge, Massachusetts
- County: Middlesex County (FIPS 25017). https://abierto.us/counties/middlesex-county-ma-25017
- City: Cambridge. https://abierto.us/cities/cambridge-ma-2511000
- First posted: September 30, 2024
- Last posted: September 30, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/d2c681896e5a473da99e52c08bb8230e/view

## Description

Amsel Medical Corporation, Cambridge, MA, was awarded a $7,453,975.00 cost-plus--fixed-fee SBIR Phase III contract. This contract provides for the development of an FDA-approved temporary vacsular occlusion clamp. Work will be performed in Cambridge, Massachusetts, and is expected to be completed 30 March 2027.

## Award on USAspending

- Recipient: Amsel Medical Corporation (UEI UUM9WLJWJQ24)
- Contract: FA238424CB015, definitive contract
- Obligated: $5,510,840.58
- Competition: Full and Open Competition, 1 offers received
- Link: award number FA238424CB015 equals the contract number; same awarding office FA2384 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_FA238424CB015_9700_-NONE-_-NONE-/


## Publications

- September 30, 2024: Award notice. Notice d2c681896e5a473da99e52c08bb8230e. https://sam.gov/workspace/contract/opp/d2c681896e5a473da99e52c08bb8230e/view

## Points of contact

- Alex LaVelle, alex.r.lavelle.4@us.af.mil

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/fa238424cb015.
